APA (7th ed.) Citation

Xing, H., Gao, M., Wang, Y., Zhang, X., Shi, J., Wang, X., . . . Meng, L. (2022). Genome‐wide gain‐of‐function screening identifies EZH2 mediating resistance to PI3Kα inhibitors in oesophageal squamous cell carcinoma. Clinical & Translational Medicine, 12(5), 1. https://doi.org/10.1002/ctm2.835

Chicago Style (17th ed.) Citation

Xing, Hui, et al. "Genome‐wide Gain‐of‐function Screening Identifies EZH2 Mediating Resistance to PI3Kα Inhibitors in Oesophageal Squamous Cell Carcinoma." Clinical & Translational Medicine 12, no. 5 (2022): 1. https://doi.org/10.1002/ctm2.835.

MLA (9th ed.) Citation

Xing, Hui, et al. "Genome‐wide Gain‐of‐function Screening Identifies EZH2 Mediating Resistance to PI3Kα Inhibitors in Oesophageal Squamous Cell Carcinoma." Clinical & Translational Medicine, vol. 12, no. 5, 2022, p. 1, https://doi.org/10.1002/ctm2.835.